PKM anticorps (Internal Region)

N° du produit ABIN6264260

Détail du produit anti-PKM anticorps

Antigène: PKM (Pyruvate Kinase M1/2 (PKM))

Épitope: Internal Region

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PKM est non-conjugé

Application: ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)

Specificité: PKM2 Antibody detects endogenous levels of total PKM2.

Homologie: Pig,Bovine,Sheep,Rabbit,Dog,Chicken,Xenopus

Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogène: A synthesized peptide derived from human PKM2, corresponding to a region within the internal amino acids.

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20 °C. Stable for 12 months from date of receipt.

Date de péremption: 12 months

Références pour anticorps anti-PKM (ABIN6264260)

Xie, Huang, Tang, Ye, Yang, Guo, Tian, Xie, Peng, Xie: "Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling." dans: Current cancer drug targets, Vol. 18, Issue 6, pp. 592-599, (2018) (PubMed).

Détails sur PKM

Antigène: PKM (Pyruvate Kinase M1/2 (PKM))

Autre désignation: PKM (PKM Produits)

Synonymes: anticorps CTHBP, anticorps OIP3, anticorps PK3, anticorps PKM2, anticorps TCB, anticorps THBP1, anticorps AA414905, anticorps AL024370, anticorps AL024424, anticorps Pk-2, anticorps Pk-3, anticorps Pk3, anticorps Pkm2, anticorps PKM12, anticorps CG7070, anticorps Dmel\\CG7070, anticorps PYK, anticorps Pyk, anticorps cb1029, anticorps fj33f03, anticorps pkm2, anticorps pkm2a, anticorps wu:fj33f03, anticorps MGC53388, anticorps PKM, anticorps PK-S, anticorps pk3, anticorps pkm2b, anticorps zgc:92037, anticorps pyruvate kinase M1/2, anticorps pyruvate kinase, muscle, anticorps Pyruvate kinase, anticorps pyruvate kinase M1/2a, anticorps pyruvate kinase PKM, anticorps pyruvate kinase (PK), anticorps pyruvate kinase, anticorps pyruvate kinase M1/2 S homeolog, anticorps pyruvate kinase M1/2b, anticorps PKM, anticorps Pkm, anticorps PyK, anticorps pkma, anticorps pkm, anticorps LOC710798, anticorps pyk, anticorps pk, anticorps LOC100534543, anticorps pkm.S, anticorps pkmb

Sujet:

Description: Glycolytic enzyme that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate (PEP) to ADP, generating ATP. Stimulates POU5F1-mediated transcriptional activation. Plays a general role in caspase independent cell death of tumor cells. The ratio between the highly active tetrameric form and nearly inactive dimeric form determines whether glucose carbons are channeled to biosynthetic processes or used for glycolytic ATP production. The transition between the 2 forms contributes to the control of glycolysis and is important for tumor cell proliferation and survival.

Gene: PKM

Poids moléculaire: 58 kDa

ID gène: 5315

UniProt: P14618

Pathways: L'effet Warburg